What is QTTB's health score?

Q32 Bio Inc. (QTTB) has a TradeApes health score of 49 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is QTTB's estimated fair value?

Based on our 5-year discounted cash flow model, Q32 Bio Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is QTTB undervalued or overvalued?

Our model currently rates QTTB as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

3 free score cards remaining

Q32 Bio Inc. (QTTB)

Healthcare Inconclusive inconclusive mixed

$15.7

Updated: 2026-07-16

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

60 Healthy

Relative Value

25 Stressed

Capital Allocation

40 Weak

Risk Management

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

Industry Related Stocks

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH) AbbVie Inc. (ABBV) AbCellera Biologics Inc. (ABCL)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.